Ataxia Telangiectasia Diagnosed on Newborn Screening–Case Cohort of 5 Years' Experience
Tóm tắt
Từ khóa
Tài liệu tham khảo
McKinnon, 2012, ATM and the molecular pathogenesis of ataxia telangiectasia, Ann Rev Pathol., 7, 303, 10.1146/annurev-pathol-011811-132509
Ambrose, 2013, Pathogenesis of ataxia-telangiectasia: the next generation of ATM functions, Blood., 121, 4036, 10.1182/blood-2012-09-456897
Schon, 2019, Genotype, extrapyramidal features, and severity of variant ataxia-telangiectasia, Ann Neurol, 85, 170, 10.1002/ana.25394
Seidel, 2019, The European Society for Immunodeficiencies (ESID) registry working definitions for the clinical diagnosis of inborn errors of immunity, J Aller Clin Immun, 7, 1763, 10.1016/j.jaip.2019.02.004
Bredemeyer, 2006, ATM stabilizes DNA double-strand-break complexes during V(D)J recombination, Nature., 442, 466, 10.1038/nature04866
Borte, 2012, Neonatal screening for severe primary immunodeficiency diseases using high-throughput triplex real-time PCR, Blood., 119, 2552, 10.1182/blood-2011-08-371021
Lumsden, 2004, Immunoglobulin class switch recombination is impaired in atm-deficient mice, J Exp Med., 200, 1111, 10.1084/jem.20041074
Reina-San-Martin, 2004, ATM is required for efficient recombination between immunoglobulin switch regions, J Exp Med., 200, 1103, 10.1084/jem.20041162
van Os, 2018, Ataxia-telangiectasia: immunodeficiency and survival, Clin Immunol, 178, 45, 10.1016/j.clim.2017.01.009
Azarsiz, 2014, Do elevated serum IgM levels have to be included in probable diagnosis criteria of patients with Ataxia-telangiectasia?, Int J Immunopathol Pharmacol, 27, 421, 10.1177/039463201402700312
Aghamohammadi, 2010, Ataxia-telangiectasia in a patient presenting with hyper-immunoglobulin M syndrome, J Investig Allergol Clin Immunol, 20, 442
Noordzij, 2009, Ataxia-telangiectasia patients presenting with hyper-IgM syndrome, Arch Dis Child, 94, 448, 10.1136/adc.2008.149351
Minto, 2019, A novel ATM mutation associated with elevated atypical lymphocyte populations, hyper-IgM, and cutaneous granulomas, Clin Immunol, 200, 55, 10.1016/j.clim.2019.01.002
Rothblum-Oviatt, 2016, Ataxia telangiectasia: a review, Orphanet J Rare Dis., 11, 1, 10.1186/s13023-016-0543-7
Nowak-Wegrzyn, 2004, Immunodeficiency and infections in ataxia-telangiectasia, J Pediatr., 144, 505, 10.1016/j.jpeds.2003.12.046
Kamae, 2013, Common variable immunodeficiency classification by quantifying T-cell receptor and immunoglobulin κ-deleting recombination excision circles, J Allergy Clin Immunol., 131, 1437, 10.1016/j.jaci.2012.10.059
de Felipe, 2016, Prospective neonatal screening for severe T- and B-lymphocyte deficiencies in Seville, Pediatr Allergy Immunol., 27, 70, 10.1111/pai.12501
Nourizadeh, 2018, Newborn screening using TREC/KREC assay for severe T and B cell lymphopenia in Iran, Scand J Immunol, 2018, e12699, 10.1111/sji.12699
Driessen, 2013, Antibody deficiency in patients with ataxia telangiectasia is caused by disturbed b- and t-cell homeostasis and reduced immune repertoire diversity, J Allergy Clin Immunol., 131, 1367, 10.1016/j.jaci.2013.01.053
Suresh, 2019, Time-dependent decline of T-cell receptor excision circle levels in ZAP-70 deficiency, J Allergy Clin Immunol Pract, 10.1016/j.jaip.2019.08.018
Sharfe, 2014, Fatal combined immunodeficiency associated with heterozygous mutation in STAT1, J Aller Clin Immunol., 133, 807, 10.1016/j.jaci.2013.09.032
Stavropoulos, 2016, Whole genome sequencing expands diagnostic utility and improves clinical management in paediatric medicine, NPJ Genom Med., 1, 15012, 10.1038/npjgenmed.2015.12
Wang, 2010, ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data, Nucleic Acids Res., 38, e164, 10.1093/nar/gkq603
Boyle, 2007, Population prevalence of diagnosed primary immunodeficiency diseases in the United States, J Clini Immunol., 27, 497, 10.1007/s10875-007-9103-1
Modell, 2018, Global report on primary immunodeficiencies: 2018 update from the jeffrey modell centers network on disease classification, regional trends, treatment modalities, and physician reported outcomes, Immunol Res., 66, 367, 10.1007/s12026-018-8996-5
Bousfiha, 2013, Primary immunodeficiency diseases worldwide: more common than generally thought, J Clin Immunol., 33, 1, 10.1007/s10875-012-9751-7
Teive, 2015, Ataxia-telangiectasia - a historical review and a proposal for a new designation: ATM syndrome, J Neurol Sci., 355, 3, 10.1016/j.jns.2015.05.022
Kwan, 2015, History and current status of newborn screening for severe combined immunodeficiency, Semin Perinatol., 39, 194, 10.1053/j.semperi.2015.03.004
Biggs, 2017, Newborn screening for severe combined immunodeficiency: a primer for clinicians, CMAJ, 189, E1551, 10.1503/cmaj.170561
Reid, 2017, Managing newborn screening for SCID in a referral centre, LymphoSign J, 4, 77, 10.14785/lymphosign-2017-0005
Mallott, 2013, Newborn screening for SCID identifies patients with ataxia telangiectasia, J Clin Immunol, 33, 540, 10.1007/s10875-012-9846-1